Tuberculosis Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Building a tuberculosis-free world
A newLancet Commission maps out priorities in diagnosis, treatment, prevention, and advocacy efforts to end tuberculosis by 2030. Detailed discussion with two of the commissioners: UN Tuberculosis Special Envoy Eric Goosby, and Paula Fujiwara from the International Union against tuberculosis and lung disease. The podcast is introduced by Liz Zuccala fromThe Lancet. (Source: Listen to The Lancet)
Source: Listen to The Lancet - March 20, 2019 Category: General Medicine Authors: The Lancet Source Type: podcasts

Xpert ® MTB/RIF test for diagnosing extrapulmonary tuberculosis and rifampicin resistance
Most Cochrane Reviews look at the effects of interventions on health, but a growing number are providing g evidence on the accuracy of different ways of diagnosing a disease. These were added to in August 2018 by a new review on a test used in the management of tuberculosis. The review ’s first author, Mikashmi Kohli from McGill University in Montreal Canada, sets the scene and tells us what they found in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 26, 2018 Category: General Medicine Authors: Cochrane Source Type: podcasts

Surgery vs. Physical Therapy for Meniscal Tears, Treatment of Subclinical Hypothyroidism, Fauci on Tuberculosis, Rheumatoid Arthritis Review, and more
Editor's Summary by Phil Fontanarosa, MD, Executive Editor of JAMA, the Journal of the American Medical Association, for the October 02, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - October 2, 2018 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Mdrtb
With 2018 being declared a year for action against TB, Pam Das and Dick Menzies discuss a study that informs the recent change in WHO treatment guidelines for multi-drug resistant tuberculosis worldwide. (Source: Listen to The Lancet)
Source: Listen to The Lancet - September 7, 2018 Category: General Medicine Authors: The Lancet Source Type: podcasts

Have we misunderstood TB's timeline?
The number of people estimated to be latently infected with TB - that is infected with TB, which has not yet manifested symptoms - is around 2 billion. That is 1 in 3 people on the planet are infected by the bacteria. The World Health Organization ’s website notes that on average 5-10% of those infected with TB will develop active TB. That number is terrifying, but a new analysis published in the BMJ, suggests that the assumption that latent TB often has a very long incubation period of many years may be wrong - and that may change how we calculate the number of people affected, and our whole approach to tackling the di...
Source: The BMJ Podcast - August 23, 2018 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts

Have we misunderstood TB ’s timeline?
The number of people estimated to be latently infected with TB - that is infected with TB, which has not yet manifested symptoms - is around 2 billion. That is 1 in 3 people on the planet are infected by the bacteria. The World Health Organization’s website notes that on average 5-10% of those infected with TB will develop active TB. That number is terrifying, but a new analysis published in the BMJ, suggests that the assumption that latent TB often has a very long incubation period of many years may be wrong - and that may change how we calculate the number of people affected, and our whole approach to tackling the dis...
Source: The BMJ Podcast - August 23, 2018 Category: General Medicine Authors: BMJ Group Source Type: podcasts

Deep Learning at Chest Radiography (August 2017)
ARTICLE DISCUSSED: Deep Learning at Chest Radiography: Automated Classification of Pulmonary Tuberculosis by Using Convolutional Neural Networks. Radiology 2017;284(2):574-582. (Source: Radiology Podcasts)
Source: Radiology Podcasts - July 19, 2017 Category: Radiology Authors: The Radiological Society of North America Tags: Podcasts Source Type: podcasts

Latent Tuberculosis: New Testing Recommendations
CDC supports the new USPSTF recommendations for latent tuberculosis testing, and a larger role for primary care clinicians in identifying patients for testing. (Source: Medscape Infectious Disease Podcast)
Source: Medscape Infectious Disease Podcast - December 19, 2016 Category: Infectious Diseases Authors: Medscape Source Type: podcasts

USPSTF Recommendation: Screening for Latent Tuberculosis in Adults
Interview with Francisco A.R. García, MD, MPH, author of Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - September 6, 2016 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

The importance of educating stem cell transplant recipients about tuberculosis and cytomegalovirus
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, discusses the importance about educating stem cell transplant patients about the risk of tuberculosis and cyt... Author: VJHemOnc Added: 04/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2016 Category: Cancer & Oncology Source Type: podcasts

Overview of the T-SPOT assay for diagnosing tuberculosis and cytomegalovirus
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, provides an overview of a symposium on the role of immunodiagnostics for tuberculosis (TB) and cytomegaloviru... Author: VJHemOnc Added: 04/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 19, 2016 Category: Cancer & Oncology Source Type: podcasts

T-SPOT assay for tuberculosis and cytomegalovirus - benefits, results and next steps
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, discusses the T-SPOT.TB assay for predicting tuberculosis (TB) and cytomegalovirus (CMV) in stem cell transpl... Author: VJHemOnc Added: 04/18/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 18, 2016 Category: Cancer & Oncology Source Type: podcasts

Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, provides an overview of an symposium on the role of tuberculosis (TB) and cytomegalovirus (CMV) immunodiagnos... Author: VJHemOnc Added: 04/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - April 13, 2016 Category: Cancer & Oncology Source Type: podcasts